Activity Overview
This educational activity is an archive
of the live conference held from January 23 to 25, 2026.
Target Audience
This educational activity is intended for oncologists involved in
the treatment and management of patients with lung cancer. Nurse practitioners,
nurses, physician assistants, pharmacists, clinical investigators, fellows, and
other health care professionals interested in the treatment of lung cancer may
also participate.
Learning Objectives
- Evaluate efficacy and safety data from recent clinical trials on established and emerging therapeutic approaches for lung cancer.
Julie R. Brahmer, MD, MSc, FASCO
Director, Thoracic Oncology Program
Kimmel Cancer Center at Johns Hopkins Bayview
Professor of Oncology
Johns Hopkins Kimmel Cancer Center
Baltimore, MD
Mark G. Kris, MD
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
Coral Olazagasti, MD
Assitant Professor of Clinical Medical Oncology
Sylvester Comprehensive Cancer, University of Miami Health System
Coral Gables, FL
Lyudmila Bazhenova, MD
Medical Oncologist
Professor of Medicine
University of California San Diego Moores Cancer Center
San Diego, CA
Rami Manochakian, MD, FASCO
Associate Professor of Medicine
Consultant, Thoracic Oncology
Program Director, Hematology/Oncology Fellowship
Vice Chair- Education, Division of Hematology/Oncology
Department of Medicine
Mayo Clinic Florida
Christine Hann, MD, PhD
Associate Professor of Oncology
Johns Hopkins University School of Medicine
Baltimore, MD
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.